A thermoresponsive polydiolcitrate-gelatin scaffold and delivery system mediates effective bone formation from BMP9-transduced mesenchymal stem cells

Successful bone tissue engineering requires at the minimum sufficient osteoblast progenitors, efficient osteoinductive factors, and biocompatible scaffolding materials. We previously demonstrated that bone morphogenetic protein 9 (BMP9) is one of the most potent factors in inducing osteogenic differentiation of mesenchymal stem cells (MSCs). Here, we investigated the potential use of a biodegradable citrate-based thermosensitive macromolecule, poly(polyethyleneglycol citrate-co-N-isopropylacrylamide) (PPCN) mixed with gelatin (PPCNG) as a scaffold for the delivery of BMP9-stimulated MSCs to promote localized bone formation. The addition of gelatin to PPCN effectively enhanced the cell adhesion and survival properties of MSCs entrapped within the gel in 3D culture. Using the BMP9-transduced MSC line immortalized mouse embryonic fibroblasts (iMEFs), we found that PPCNG facilitated BMP9-induced osteogenic differentiation of iMEFs in vivo and promoted the formation of well-ossified and vascularized trabecular bone-like structures in a mouse model of ectopic bone formation. Histologic evaluation revealed that vascularization of the bony masses retrieved from the iMEFs  +  PPCNG group was significantly more pronounced than that of the direct cell injection group. Accordingly, vascular endothelial growth factor (VEGF) expression was shown to be significantly higher in the bony masses recovered from the iMEFs  +  PPCNG group. Taken together, our results suggest that PPCNG may serve as a novel biodegradable and injectable scaffold and carrier for gene and cell-based bone tissue engineering.

[1]  T. He,et al.  BMP9 signaling in stem cell differentiation and osteogenesis. , 2018, American journal of stem cells.

[2]  Maryam K. Mohammed,et al.  Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells , 2015, Scientific Reports.

[3]  Maryam K. Mohammed,et al.  The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation , 2015, Cellular Physiology and Biochemistry.

[4]  A. Khademhosseini,et al.  Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. , 2015, Biomaterials.

[5]  Maryam K. Mohammed,et al.  The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: Implications in targeted cancer therapies , 2015, Laboratory Investigation.

[6]  T. He,et al.  A Novel Organ Culture Model of Mouse Intervertebral Disc Tissues , 2015, Cells Tissues Organs.

[7]  Q. Han,et al.  Preformed gelatin microcryogels as injectable cell carriers for enhanced skin wound healing. , 2015, Acta biomaterialia.

[8]  T. He,et al.  The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways. , 2015, Current cancer drug targets.

[9]  Y. Tabata,et al.  Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction , 2015, PloS one.

[10]  Ying-Chieh Chen,et al.  Enzymatic regulation of functional vascular networks using gelatin hydrogels. , 2015, Acta biomaterialia.

[11]  T. He,et al.  Reversibly Immortalized Mouse Articular Chondrocytes Acquire Long-Term Proliferative Capability While Retaining Chondrogenic Phenotype , 2015, Cell transplantation.

[12]  Xiaohua Liu,et al.  Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis. , 2015, Acta biomaterialia.

[13]  T. He,et al.  Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system , 2015, Genes & diseases.

[14]  Jing Wang,et al.  Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance , 2014, Genes & diseases.

[15]  T. He,et al.  A Simplified and Versatile System for the Simultaneous Expression of Multiple siRNAs in Mammalian Cells Using Gibson DNA Assembly , 2014, PloS one.

[16]  Ajazuddin,et al.  Polyethylene glycol (PEG)-Poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  Jian Yang,et al.  A thermoresponsive biodegradable polymer with intrinsic antioxidant properties. , 2014, Biomacromolecules.

[18]  L. Yin,et al.  The versatile functions of Sox9 in development, stem cells, and human diseases , 2014, Genes & diseases.

[19]  Evan M. Farina,et al.  Fibroblast growth factor (FGF) signaling in development and skeletal diseases , 2014, Genes & diseases.

[20]  Paul C. Wang,et al.  Biosafe nanoscale pharmaceutical adjuvant materials. , 2014, Journal of biomedical nanotechnology.

[21]  R. Haydon,et al.  Bone Morphogenetic Protein (BMP) signaling in development and human diseases , 2014, Genes & diseases.

[22]  T. He,et al.  Bone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla. , 2014, Stem cells and development.

[23]  T. He,et al.  The piggyBac Transposon-Mediated Expression of SV40 T Antigen Efficiently Immortalizes Mouse Embryonic Fibroblasts (MEFs) , 2014, PloS one.

[24]  X. Chen,et al.  Overexpression of Ad5 precursor terminal protein accelerates recombinant adenovirus packaging and amplification in HEK-293 packaging cells , 2014, Gene Therapy.

[25]  T. He,et al.  Characterization of Constitutive Promoters for piggyBac Transposon-Mediated Stable Transgene Expression in Mesenchymal Stem Cells (MSCs) , 2014, PloS one.

[26]  T. He,et al.  Adenovirus-Mediated Efficient Gene Transfer into Cultured Three-Dimensional Organoids , 2014, PloS one.

[27]  T. He,et al.  Adenovirus-Mediated Gene Transfer in Mesenchymal Stem Cells Can Be Significantly Enhanced by the Cationic Polymer Polybrene , 2014, PloS one.

[28]  T. He,et al.  Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling. , 2014, Current cancer drug targets.

[29]  Ahmed O Elzoghby,et al.  Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[30]  T. He,et al.  Crosstalk between Wnt/β-Catenin and Estrogen Receptor Signaling Synergistically Promotes Osteogenic Differentiation of Mesenchymal Progenitor Cells , 2013, PloS one.

[31]  T. He,et al.  Characterization of chondrocyte scaffold carriers for cell-based gene therapy in articular cartilage repair. , 2013, Journal of biomedical materials research. Part A.

[32]  T. He,et al.  Destabilization of Heterologous Proteins Mediated by the GSK3β Phosphorylation Domain of the β-Catenin Protein , 2013, Cellular Physiology and Biochemistry.

[33]  T. He,et al.  Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[34]  T. He,et al.  The E-F Hand Calcium-Binding Protein S100A4 Regulates the Proliferation, Survival and Differentiation Potential of Human Osteosarcoma Cells , 2013, Cellular Physiology and Biochemistry.

[35]  T. He,et al.  Characterization of scaffold carriers for BMP9-transduced osteoblastic progenitor cells in bone regeneration. , 2013, Journal of biomedical materials research. Part A.

[36]  T. He,et al.  Endoplasmic Reticulum (ER) Stress Inducible Factor Cysteine-Rich with EGF-Like Domains 2 (Creld2) Is an Important Mediator of BMP9-Regulated Osteogenic Differentiation of Mesenchymal Stem Cells , 2013, PloS one.

[37]  T. He,et al.  IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma. , 2013, Cancer letters.

[38]  T. He,et al.  Cross-talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cells , 2013, Journal of cellular and molecular medicine.

[39]  T. He,et al.  Establishment and Characterization of the Reversibly Immortalized Mouse Fetal Heart Progenitors , 2013, International journal of medical sciences.

[40]  Jay R Lieberman,et al.  Gene therapy for bone regeneration. , 2013, Current pharmaceutical design.

[41]  T. He,et al.  Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways , 2013, Oncology reports.

[42]  R. Franceschi,et al.  Advanced BMP Gene Therapies for Temporal and Spatial Control of Bone Regeneration , 2013, Journal of dental research.

[43]  T. He,et al.  Wnt signaling in bone formation and its therapeutic potential for bone diseases , 2013, Therapeutic advances in musculoskeletal disease.

[44]  T. He,et al.  BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells , 2013, Journal of Cell Science.

[45]  E. Schwarz,et al.  Gene therapy approaches to regenerating bone. , 2012, Advanced drug delivery reviews.

[46]  K. G. Guruharsha,et al.  The Notch signalling system: recent insights into the complexity of a conserved pathway , 2012, Nature Reviews Genetics.

[47]  G. Prestwich,et al.  Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel. , 2012, Biomaterials.

[48]  T. He,et al.  Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  S. Artavanis-Tsakonas,et al.  Notch and disease: a growing field. , 2012, Seminars in cell & developmental biology.

[50]  Stephen M Warren,et al.  Bone tissue engineering: current strategies and techniques--part I: Scaffolds. , 2012, Tissue engineering. Part B, Reviews.

[51]  Akikazu Ishihara,et al.  Cell-mediated and direct gene therapy for bone regeneration , 2012, Expert opinion on biological therapy.

[52]  W. Khan,et al.  Advances in the use of stem cells and tissue engineering applications in bone repair. , 2012, Current stem cell research & therapy.

[53]  T. He,et al.  Conditionally Immortalized Mouse Embryonic Fibroblasts Retain Proliferative Activity without Compromising Multipotent Differentiation Potential , 2012, PloS one.

[54]  Peter X Ma,et al.  Biomimetic nanofibrous scaffolds for bone tissue engineering. , 2011, Biomaterials.

[55]  Andrea Barbetta,et al.  Human cardiosphere-seeded gelatin and collagen scaffolds as cardiogenic engineered bioconstructs. , 2011, Biomaterials.

[56]  J. Qin,et al.  Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma , 2011, Oncogene.

[57]  T. He,et al.  Epigenetic Regulation of Mesenchymal Stem Cells: A Focus on Osteogenic and Adipogenic Differentiation , 2011, Stem cells international.

[58]  T. He,et al.  BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. , 2011, Current gene therapy.

[59]  H. Kleinman,et al.  Multiple uses of basement membrane‐like matrix (BME/Matrigel) in vitro and in vivo with cancer cells , 2011, International journal of cancer.

[60]  T. He,et al.  Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer , 2011, Molecular Pharmacology.

[61]  T. He,et al.  Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials , 2010, Stem cells international.

[62]  Yang Bi,et al.  Mesenchymal stem cells: Molecular characteristics and clinical applications. , 2010, World journal of stem cells.

[63]  T. He,et al.  Retinoic Acids Potentiate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells , 2010, PloS one.

[64]  A. Khademhosseini,et al.  Cell-laden microengineered gelatin methacrylate hydrogels. , 2010, Biomaterials.

[65]  T. He,et al.  Insulin-like Growth Factor 2 (IGF-2) Potentiates BMP-9-Induced Osteogenic Differentiation and Bone Formation , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[66]  T. He,et al.  Synergistic Antitumor Effect of the Activated PPARγ and Retinoid Receptors on Human Osteosarcoma , 2010, Clinical Cancer Research.

[67]  E. Canalis,et al.  Notch and the Skeleton , 2009, Molecular and Cellular Biology.

[68]  H. Burt,et al.  The differential in vitro and in vivo responses of bone marrow stromal cells on novel porous gelatin–alginate scaffolds , 2009, Journal of tissue engineering and regenerative medicine.

[69]  K. Popat,et al.  Bone tissue engineering: A review in bone biomimetics and drug delivery strategies , 2009, Biotechnology progress.

[70]  T. He,et al.  BMP‐9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signalling , 2009, Journal of cellular and molecular medicine.

[71]  T. He,et al.  A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. , 2009, Stem cells and development.

[72]  T. He,et al.  Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells* , 2009, Journal of Biological Chemistry.

[73]  A. Montag,et al.  Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects , 2008, Laboratory Investigation.

[74]  A. Raucci,et al.  Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways , 2008, Journal of cellular physiology.

[75]  A. Montag,et al.  Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[76]  K. Kinzler,et al.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system , 2007, Nature Protocols.

[77]  H. Kleinman,et al.  Matrigel: basement membrane matrix with biological activity. , 2005, Seminars in cancer biology.

[78]  J. Wrana,et al.  The disparate role of BMP in stem cell biology , 2005, Oncogene.

[79]  A. Montag,et al.  Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[80]  J. Szatkowski,et al.  Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery , 2004, Gene Therapy.

[81]  Wei Jiang,et al.  Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[82]  Hongwei Cheng,et al.  Transcriptional characterization of bone morphogenetic proteins (BMPs)‐mediated osteogenic signaling , 2003, Journal of cellular biochemistry.

[83]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs) 1 1 J Bone Joint Surg Am 2003;85A:1544–52 , 2003 .

[84]  A. Montag,et al.  Cytoplasmic and/or nuclear accumulation of the β‐catenin protein is a frequent event in human osteosarcoma , 2002, International journal of cancer.

[85]  A. Montag,et al.  Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[86]  Kodjo Boady Djagny,et al.  Gelatin: A Valuable Protein for Food and Pharmaceutical Industries: Review , 2001, Critical reviews in food science and nutrition.

[87]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[88]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[89]  T. He,et al.  Canonical Wnt signaling acts synergistically on BMP9-induced osteo/odontoblastic differentiation of stem cells of dental apical papilla (SCAPs). , 2015, Biomaterials.

[90]  王金华,et al.  Bone morphogenetic protein-9 effectively induces osteo/odontoblastic differentiation of the reversibly immortalized stem cells of dental apical papilla , 2014 .

[91]  Ilker S. Bayer,et al.  Advances in bionanomaterials for bone tissue engineering. , 2013, Journal of nanoscience and nanotechnology.

[92]  Ilker S. Bayer,et al.  Effect of intracerebroventricular injection of Ti-02 nanoparticles on complex behavior in the rat , 2013 .

[93]  H. Demirkiran.  Bioceramics for osteogenesis, molecular and cellular advances. , 2012, Advances in experimental medicine and biology.

[94]  A. Montag,et al.  Regulation of osteogenic differentiation during skeletal development. , 2008, Frontiers in bioscience : a journal and virtual library.

[95]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.

[96]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.